SCHEMBL4673207

SCHEMBL4673207

CC(C)c1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NC(CO)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 4/20 0.40
FEN1 P39748 4/20 0.40
ALDH1A1 P00352 2/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
KCNH2 Q12809 2/20 0.38
MMP1 P03956 2/20 0.38
MMP2 P08253 2/20 0.38
MMP3 P08254 2/20 0.38
MMP7 P09237 2/20 0.38
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38
MMP8 P22894 1/20 0.37
MMP14 P50281 1/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD11B1 P28845 1/20 0.36
TDO2 P48775 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4619044 0.88 TDO2 (0.46) ALOX5APFEN1ALDH1A1CA1CA2
SCHEMBL4617754 0.81 CA1 (0.44) ALDH1A1CA1CA2HTR2AHTR2C
SCHEMBL4619047 0.79 CA1 (0.50) ALOX5APFEN1ALDH1A1CA1CA2
SCHEMBL28775084 0.77 SFRP1 (0.42) ALOX5APFEN1ALDH1A1LMNASMN1; SMN2
SCHEMBL4617178 0.77 CA1 (0.48) ALDH1A1CA1CA2HTR2AHTR2C
SCHEMBL4618921 0.75 SFRP1 (0.51)
SCHEMBL4617920 0.75 HTR1A (0.45) HTR2A
SCHEMBL4616844 0.74 HTR2C (0.43) ALDH1A1CA1CA2HTR2AHTR2C
SCHEMBL6102667 0.74 CA1 (0.47) ALDH1A1CA1CA2HTR2AHTR2C
SCHEMBL4616319 0.74 PDE4A (0.46) ALOX5APFEN1ALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 ALOX5AP 3153/4885FEN1 4380/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.